Semaglutide treatment for obesity in teenagers: a plain language summary of the STEP TEENS research study

• DOI: 10.2217/cer-2022-0187
• Publication Date: 2022-12-19T16:45:51Z
• Authors: Daniel Weghuber; Klaus Boberg; Dan Hesse; Ole K Jeppesen; Rasmus Sørrig; Aaron S Kelly
• Keywords: Semaglutide; Anti obesity; Placebo group

What is this summary about? This a plain language of the STEP TEENS research study, which was originally published in New England Journal Medicine . As more teenagers are living with obesity than ever before, researchers searching for new treatments. first study looking at how well medicine semaglutide works as treatment teenagers. were results? In looked effect on body mass index (BMI) and weight loss compared to dummy (placebo). A 17% decrease BMI reported treated placebo. For loss, an 18 kg seen when comparing Researchers found that there who had 5%, 10%, 15%, 20% or group given Improvements also some risk factors other diseases caused by obesity. Semaglutide generally tolerated serious medication side effects did not happen very often. do results mean? The from showed no safety issues obesity, can be used help them lose weight. Clinical Trial Registration : NCT04102189 ( ClinicalTrials.gov )